Vendor source
Reviewed 29 Sept 2026
Completeness Strong (75%)
cNeuro cMRI is a tool for quantitative assessment of MRI brain images. Volumes of 133 brain structures, as well as disease specific biomarkers are extracted from T1 images and white matter hyperintensities (WMH) are extracted from FLAIR images. Extracted information is compared to a normative database and deviations from normal are highlighted. cMRI can be used both for cross-sectional and longitudinal analysis. cNeuro cMRI results are sent back to PACS, but there is also an interactive viewer for exploring results.
Supported by 6 papers
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIa
Verified by Health AI Register
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment
Neurology · Aug 2026
Orbitofrontal atrophy on MRI appears to be an indicator of C9orf72 repeat expansion status in FTD
Journal of Neuroradiology · Jun 2026
Brain ventricle morphology markers in predicting shunt surgery outcome in idiopathic normal-pressure hydrocephalus
Fluids and Barriers of the CNS · Apr 2026
Automatically computed rating scales from MRI for patients with cognitive disorders
European Radiology · Feb 2019
Detecting frontotemporal dementia syndromes using MRI biomarkers
NeuroImage: Clinical · Feb 2019
Differential diagnosis of neurodegenerative diseases using structural MRI data
NeuroImage: Clinical · Mar 2016
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Jun 21, 2022 | Last updated: Sep 29, 2026